Receptor-binding cancer antigen (RCAS1) expression in cancer cells is linked to an immunosuppressive TME, and it was demonstrated that cytoplasmic RCAS1 expression in ovarian tumor samples correlated with a larger degree of macrophage infiltration (49). Here, EBAG9 is linked to cancer.